Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-21-024584
Filing Date
2021-05-05
Accepted
2021-05-04 21:14:05
Documents
59
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K f10k2020a1_cmlifesciences.htm 10-K/A 818879
2 CERTIFICATION f10k2020ex31-1_cmlife.htm EX-31.1 13091
3 CERTIFICATION f10k2020ex31-2_cmlife.htm EX-31.2 13070
4 CERTIFICATION f10k2020ex32-1_cmlife.htm EX-32.1 5491
5 CERTIFICATION f10k2020ex32-2_cmlife.htm EX-32.2 5541
  Complete submission text file 0001213900-21-024584.txt   3527661

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cmlf-20201231.xml EX-101.INS 430813
7 XBRL SCHEMA FILE cmlf-20201231.xsd EX-101.SCH 57772
8 XBRL CALCULATION FILE cmlf-20201231_cal.xml EX-101.CAL 21065
9 XBRL DEFINITION FILE cmlf-20201231_def.xml EX-101.DEF 214013
10 XBRL LABEL FILE cmlf-20201231_lab.xml EX-101.LAB 386137
11 XBRL PRESENTATION FILE cmlf-20201231_pre.xml EX-101.PRE 219882
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020 212 474 6700
CM Life Sciences, Inc. (Filer) CIK: 0001818331 (see all company filings)

EIN.: 851966622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39482 | Film No.: 21890859
SIC: 6770 Blank Checks